Nano Miscellaneous
Market Cap
₹310 ₹310 Cr.
P/E
192.88
PEG = P/E ÷ 5yr Forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

Key Ratios

Debt to Equity
Debt to Equity
0.87
Div Yield (%)
Div Yield (%)
-
Individual < 2 lac
Individual < 2 lac
23.18 %
Institutions
Institutions
0.10 %
Market cap
Market cap
310 Cr
No. of Shareholders
No. of Shareholders
1.45 L
OPM (%)
OPM (%)
1.90 %
PE
PE
192
Prom Holding
Prom Holding
3.36 %
ROCE (%)
ROCE (%)
0.16
ROE (%)
ROE (%)
0.09
Sales
Sales
103 Cr
  • Evexia Lifecare
  • Sanginita Chemicals
  • A-1
Last updated on 11 Sep 2026
  • Evexia Lifecare is mainly a stock-in-trade trading business with healthcare subsidiaries and a new EV-rental division called Go EVEXIA.
  • Its edible-oil manufacturing has been suspended since March 2019. Trading is now the core activity.
  • Profit comes from stock-in-trade trading. The EV-rental and healthcare businesses have almost no reported revenue yet.
  • It can now operate in EVs, automobiles, vehicle services and charging infrastructure. No capex or funding for this shift is filed yet.
  • Consolidated investments were ₹718Cr against ₹873Cr of assets. Cash was only ₹2.38Cr.
  • Near-term profit depends on whether higher trading revenue turns into operating cash.
  • Audit gaps persist across loans, receivables and investments. Prior reports also carried adverse or qualified language.
  • FCCB conversion allotment Imminently; redemption 3 Feb 2028
    It shows the shares issued for 50 bonds and the dilution.
  • Audit evidence in Q2 review ~mid-Nov
    It shows whether evidence on ₹29.44Cr receivables, ₹7.35Cr loans and investments improves.
  • Promoter buying run No timeline
    It shows whether buying beyond 4.164% continues and if others join.
  • EV funding and allocation No timeline; by next annual report
    It shows what capital goes to EVs against ₹2.72L quarterly revenue.
Price Range

See where the stock is trading versus its 52-week high and low.

Low
0
52W Range
High
2
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

7 Yes

Positive for this company

0 Neutral

Neutral for this company

9 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

FAQs on Evexia Lifecare Ltd. Business

Evexia Lifecare Limited, formerly known as Kavit Industries Limited, was established in 1990 in Vadodara. Specializing in trading chemicals, agriculture produce, and consumer goods.

Evexia Lifecare major competitors are Sanginita Chemicals, A-1, Narmada Gelatines, India Gelatine &Chem, Hind Organic Chem, Naperol Investments, Cochin Minerals&Rut..
Market Cap of Evexia Lifecare is ₹310 Crs.
While the median market cap of its peers are ₹281 Crs.

Evexia Lifecare seems to be less financially stable compared to its competitors.
Altman Z score of Evexia Lifecare is 0.5 and is ranked 8 out of its 8 competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material